Mark S. Diamond

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity”.

Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1918971117

N/A

0DataRank · unranked

142 citations

Mark S. Diamond, Ceire Hay, Katelyn T. Byrne, Robert H. Vonderheide, Alexander H. Morrison

Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming

Cancer Immunology Research(2021)10.1158/2326-6066.cir-20-0785

N/A

0DataRank · unranked

28 citations

Jeffrey Lin, Robert H. Vonderheide, Mark S. Diamond

Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy

Research Square(2023)10.21203/rs.3.rs-2960521/v1

N/A

0DataRank · unranked

3 citations

Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Qinglan Li, Jeffrey H. Lin +10 more

Data from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming

(2023)10.1158/2326-6066.c.6550629.v1

N/A

0DataRank · unranked

0 citations

Jeffrey Lin, Robert H. Vonderheide, Mark S. Diamond

Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-46048-7

N/A

0DataRank · unranked

28 citations

Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Benjamin Kahn, Qinglan Li +12 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more